AMERICAN CLINICAL LABORATORY ASSN lobbying for AMERICAN CLINICAL LABORATORY ASSN

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Expenses

$930,000.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

LAURA STEVENS KENT New on this filing

Previously held: Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 5269
RESULTS Act
S 2761
RESULTS Act

Lobbying activity 3

Medical/Disease Research/Clinical Labs

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostic regulatory reform.

Medicare/Medicaid

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93).

Health Issues

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; RESULTS Act (H.R. 5269/S. 2761); implementation of the Protecting Access to Medicare Act (P.L. 113-93); diagnostics regulatory reform; price transparency requirements for clinical laboratory services.